ARCHIVES

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

Raloxifene Protects Women At High or Low Risk of Disease

September 29, 2006

Detroit’s “Dr. Vee” Honored For 50 Years In Medicine.

November 9, 2001

NCAB Cool On CCOP, Ponders Questions On Distribution, Numbers Of Centers

December 11, 1981

BRMP Projects Priority Rated

April 11, 1980

Van Brings Free Brain MRIs To Capitol Hill; Experts See Enormous Potential For Harm

May 8, 2009

Lenalidomide, An Altered Thalidomide, Shows Promise

November 24, 2006